Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02264990
Title	Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Subjects Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer Who Are Current or Former Smokers
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	AbbVie
Indications	lung non-small cell carcinoma
Therapies	Pemetrexed Disodium Carboplatin Paclitaxel Veliparib Cisplatin
Age Groups:	adult
Covered Countries	USA \| TUR \| NZL \| NLD \| ISR \| HUN \| GBR \| FIN \| ESP \| DNK \| DEU \| CZE \| CAN \| AUS \| ARG